MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease

R. Moraes, J. Freitas, R. Ferreira, P. Pereira, P. Terzian, F. Godinho, M. Rocha (Sao Paulo, Brazil)

Meeting: 2019 International Congress

Abstract Number: 984

Keywords: Deep brain stimulation (DBS), Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To evaluate patient-centered outcomes after deep brain stimulation in Parkinson’s disease.

Background: Deep brain stimulation (DBS) is an effective treatment for Parkinson’s disease (PD) patients. Long-term outcomes have demonstrated sustained improvement in motor symptoms. However, few studies have evaluated patient-centered outcomes (PCO).

Method: A PCO questionnaire was administered to PD patients post-DBS. It measured outcomes on mobility, gait, postural instability, cognitive, speaking and psychiatric symptoms, sexual functions, pain, social life, and issues related to the DBS device. All questions were scored on a five-point Likert scale, where 4 and 5 points were the most favorable outcomes. Demographic data and Hoehn & Yahr scale (H&Y) before surgery was collected. Data on DBS therapy included the stimulation target and electric parameters.

Results: Forty-seven patients answered the questionnaire (55.3% males). Mean age was 58.3y (SD 8.7). Mean H&Y stage was 3.3 (SD 0.6), and mean DBS therapy duration was 25.5 months. Subthalamic nucleus (STN) was the target in 38 (80.8%), and Forel’s field in 9 patients. Mean amplitude, frequency and pulse-width were 2.7 V, 158 Hz and 64.5 ms. Mobility: 89.4% of patients agreed that DBS improved walk velocity in small distances (100 m), and 80.9% agreed that DBS facilitated walk (1 km). Postural instability: 85.1% of patients agreed they have better balance and 76.6% agreed they have less falls. Pain was reduced in 68.1% of patients, and sexual performance was better for 42.6%. Anxiety was reduced for 72.3% of patients, whereas depression was reduced for 80.8%. Most patients (80.6%) agreed they feel better during social activities. On the other hand, 42.6% experienced worsening of speaking, and 23.4% referred worse episodic memory. DBS device was not a problem for 85.1%. There was a non-significant trend towards lower grades in patients who had Forel’s field surgical target (mean score 162.9) compared to STN (mean score 183.3). A multivariable regression analysis showed younger age as a predictive factor for good outcomes after DBS surgery. Overall mean grade (0 to 10) for patient satisfaction with DBS therapy was 8.9, and 96.7% would undergo the surgical treatment again

Conclusion: After an average of 2 years post-DBS surgery, the majority of patients were satisfied, felt they had made the correct decision to undergo DBS and would choose to have DBS again.

table 1

To cite this abstract in AMA style:

R. Moraes, J. Freitas, R. Ferreira, P. Pereira, P. Terzian, F. Godinho, M. Rocha. Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/patient-centered-outcomes-of-deep-brain-stimulation-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/patient-centered-outcomes-of-deep-brain-stimulation-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley